Document is current
Any future updates will be listed below
-
Authors
Deben, Christophe https://orcid.org/0000-0001-8085-2040
Cardenas De La Hoz, Edgar
Rodrigues Fortes, Felicia
Le Compte, Maxim
Seghers, Sofie
Vanlanduit, Steve
Vercammen, Hendrik
Van Den Bogert, Bert
Dusetti, Nelson
Lin, Abraham
Roeyen, Geert
Peeters, Marc
Prenen, Hans https://orcid.org/0000-0001-8802-7352
Lardon, Filip
Smits, Evelien
- License Information
-
More Information
Article History
Received: 1 August 2024
Accepted: 27 November 2024
First Online: 3 December 2024
Competing interests
: The authors declare the following competing interests: C.D., M.L.C., E.C.D.L.H., and A.L. are co-founders of Orbits® Oncology, an image and data analysis platform that was used in this study.
: Pancreatic ductal adenocarcinoma (PDAC) samples were obtained from three expert clinical centers under the PaCaOmics clinical trial (number 2011-A01439-32) after receiving ethics review board approval. Consent forms of informed patients were collected and registered in a central database.
